Inteligex

inteligex.ca

Inteligex is developing innovative stem cell and drug-based therapies for traumatic spinal cord injury, aiming to be the leading personalized regenerative medicine company for treating spinal cord injury and other central nervous system diseases. Their regenerative platform is also being optimized for conditions such as cerebral palsy, stroke, multiple sclerosis, and amyotrophic lateral sclerosis, addressing a significant unmet medical need in these areas.